...
首页> 外文期刊>Psycho-Oncology: Journal of the Psychological Social and Behavioral Dimensions of Cancer >Depression treatment and healthcare expenditures among elderly Medicare beneficiaries with newly diagnosed depression and incident breast, colorectal, or prostate cancer
【24h】

Depression treatment and healthcare expenditures among elderly Medicare beneficiaries with newly diagnosed depression and incident breast, colorectal, or prostate cancer

机译:具有新诊断的抑郁症和入射乳房,结直肠癌或前列腺癌的老年人医疗保险受益者中的抑郁症治疗和医疗支出

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Objectives Depression is associated with high healthcare expenditures, and depression treatment may reduce healthcare expenditures. However, to date, there have not been any studies on the effect of depression treatment on healthcare expenditures among cancer survivors. Therefore, this study examined the association between depression treatment and healthcare expenditures among elderly with depression and incident cancer. Methods The current study used a retrospective longitudinal study design, the linked Surveillance, Epidemiology, and End Results–Medicare database. Elderly (≥66?years) fee‐for‐service Medicare beneficiaries with newly diagnosed depression and incident breast, colorectal, or prostate cancer (N?=?1502) were followed for a period of 12?months after depression diagnosis. Healthcare expenditures were measured every month for a period of 12‐month follow‐up period. Depression treatment was identified during the 6‐month follow‐up period. The adjusted associations between depression treatment and healthcare expenditures were analyzed with generalized linear mixed model regressions with gamma distribution and log link after controlling for other factors. Results The average 1‐year total healthcare expenditures after depression diagnosis were $38?219 for those who did not receive depression treatment; $42?090 for those treated with antidepressants only; $46?913 for those treated with psychotherapy only; and $51?008 for those treated with a combination of antidepressants and psychotherapy. As compared to no depression treatment, those who received antidepressants only, psychotherapy only, or a combination of antidepressants and psychotherapy had higher healthcare expenditures. However, second‐year expenditures did not significantly differ among depression treatment categories. Conclusions Among cancer survivors with newly diagnosed depression , depression treatment did not have a significant effect on expenditures in the long term.
机译:摘要目标抑郁与高医疗支出有关,抑郁症治疗可能会减少医疗保健支出。然而,迄今为止,抑郁症治疗对癌症幸存者之间的医疗费用的影响没有任何研究。因此,本研究检测了老年抑郁症和事件癌症抑郁症治疗和医疗保健支出的关联。方法采用回顾性纵向研究设计,联系监测,流行病学和最终结果 - Medicare数据库。老年人(≥66?年)使用新诊断的抑郁和入射乳房,结直肠癌或前列腺癌(N?= 1502)的服务费用,抑郁症诊断后12个月。医疗保健支出每月测量为期12个月的随访期。在6个月的随访期间鉴定了抑郁症治疗。通过控制其他因素的伽马分布和日志链路,分析了抑郁症处理和医疗保健支出之间的调整后的关联。结果抑郁症诊断后的平均1年总医疗支出为38美元,那些没有收到抑郁症治疗的人;只需用抗抑郁药治疗的人42?090; 46美元?913仅适用于使用心理治疗的人;为那些用抗抑郁药和心理治疗组合治疗的人51 001美元。与没有抑郁症治疗相比,仅接受抗抑郁药的人,只有心理治疗,或抗抑郁药和心理治疗的组合具有更高的医疗保健支出。但是,抑郁症治疗类别的第二年支出没有显着差异。结论癌症幸存者具有新诊断的抑郁症,抑郁症治疗在长期的支出没有显着影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号